The Government Says

MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balance

MHRA concludes review of Avacopan Vifor following reassessment of benefit-risk balance
Local copy of Direct_Healthcare_Professional_Communication__for_Avacopan_July_2026.pdf

https://www.gov.uk/government/news/mhra-concludes-review-of-avacopan-vifor-following-reassessment-of-benefit-risk-balance

seen at 10:52, 1 September in News and communications.